Dados B3 › AESO3 × CPLE3 · Português
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | AESO3 | CPLE3 | year |
|---|---|---|---|
| ROE | -0.6% | 11.0% | 2025 |
| ROIC | 4.5% | 10.5% | 2025 |
| ROA | 0.9% | 4.6% | 2025 |
| Gross margin | 23.5% | 21.7% | 2025 |
| EBIT margin | 17.1% | 19.3% | 2025 |
| Net margin | 2.8% | 10.3% | 2025 |
| Net debt/EBITDA | 2.69x | 2.59x | 2025 |
| Current ratio | 0.72x | 0.98x | 2025 |
| Revenue growth (1y) | 4.5% | 15.3% | 2025 |
| Revenue growth (5y CAGR) | 17.2%! | 7.0% | 2025 |
| Piotroski F-Score | 8/9 | 6/9 | 2025 |
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | AESO3 | CPLE3 | year |
|---|---|---|---|
| P/E | — | 16.52x | None × 2025 |
| P/B | — | 1.92x | None × 2025 |
| EV/EBITDA | — | 9.39x | None × 2025 |
| FCF yield | — | 6.4% | None × 2025 |
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 14:11 UTC. If this does not match /saude, you are reading a cached copy.
Home · Methodology · Transparency · Audit it